Promoted Content
Promoted Content

Overview of Ezetimibe

Client Email Product
Ezetimibe
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES
DOSSIERS
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

0

SERVICES
  • WHO-GMP
Applications: Direct compression for modified release dosage forms
Ingredient(s): EthylCellulose
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Ethylcellulose , Hydroxypropyl methyl cellulose K4M, Hydroxypropyl Cellulose, Colloidal Silicon Dioxide, Maize Starch, Magnesium Stearate and Talc
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
Applications: Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
Applications: Sustained Release Tablet Matrix
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Ingredient(s): Starch
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.
Ingredient(s): HPMC AS
Dosage Form: Capsule
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Complies with relevant European, Japanese and US Pharmacopeia monographs
Technical Specifications: Water content – less than 6%; Size #0
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available